lncRNA PCBP1-AS1 mediated downregulation of ITGAL as a prognostic biomarker in lung adenocarcinoma
Figure 6.The expression of the ITGALin immune subtype. (A, B) The expression of ITGALin immune subtype of NSCLC. (C, D) Relation between ITGAL CNV and immune cell in NSCLC. *p < 0.05.